We are only at the beginning of the aging wave when it comes to the demand for care. A large group is going to turn 75+ in the coming years, and with that the demand for care is increasing accordingly. Living at home longer is the trend, but due to the size of the elderly group and increased illnesses such as dementia, the demand for new residential care concepts and nursing home care is also increasing.
Providers that offer innovative solutions in healthcare segments that increase efficiency and quality of care can expect considerable interest from an M&A perspective.
The innovative strength in the Netherlands also provides opportunities precisely for rolling out abroad new concepts developed here. Therefore, we expect that the focus will increasingly shift to providers of innovative care concepts such as digitized care pathways, telehealth and monitoring, diagnostics, etc. Classic providers who mainly have a lot of care capacity to offer will still be in demand.
The heyday will soften after the uncertain times with rising inflation, high absenteeism and increasing pressure on affordability and financeability. All the more reason to set a clear strategic course precisely in these times.
These are issues which we would like to contemplate on together with you. Because the challenges are enormous. More and more entrepreneurship is demanded and the financing of all plans must be firmly secured.
We have been at the table with parties in healthcare for more than 25 years, advising in a variety of areas. In strategic and financial issues. In concentration and distribution, purchase, sale and mergers.
At JBR, we like to create overview and insight and believe in the combination of sensible and refreshing thinking.
You can fill out the contact form or leave a request for a callback.
We will contact you as soon as possible.
Fill out our contact form and we will get back to you as soon as possible to answer your questions.
Leave a callback request and we will call you back (possibly at a time you specify) for a no-obligation consultation.
Dedicated team
We assist you as a healthcare provider in such areas as strategic issues, corporate finance and restructuring. When you work with JBR on a transaction or assignment, you always work with the same team. That way we can provide the most added value.
International network
The innovation strength in the Netherlands offers opportunities for the rollout abroad of new concepts developed here. Attention is expected to increasingly shift to providers of innovative care concepts such as digitized care pathways, telehealth and monitoring, diagnostics, etc. These assignments can transcend national borders. Therefore, we are a member of the international REACH M&A network where international issues are taken up for you.
Track record
JBR has over 25 years of experience in M&A transactions in the Healthcare sector. As of 2020, the JBR Healthcare team has managed 40 sale and purchase transactions and strategy processes in the healthcare sector.
Dedicated team
International network
Track record
The Healthcare Monitor
This report contains the most complete overview of mergers and acquisitions/holdings in the Dutch healthcare sector over the years. We have been meticulously tracking the results since 2012.
By adding sub-segments and scoring on additional criteria, this survey provides more insight for healthcare organizations, administrators, supervisors and healthcare employees.
The starting point for the research report is the healthcare transactions announced by healthcare institutions and approved by the NZa (Dutch Healthcare Authority).
If, as a result of the above, you would like to spar with one of our advisors, we would be happy to comply.
Indeed, we are looking forward to it!
Caspar van der Geest
Partner
Thomas van Amerongen
Senior Consultant Corporate Finance
Merijn Veltkamp
Associate
Suut Tang
Associate
Sten Welboren
Business Analyst
Alexander Rutten
Business Analyst
Jelmer Haites
Consultant Corporate Finance
Pieter de Jong
Consultant
Lucas van den Berkhof
Business Analyst
Rutger Beelen
Business Analyst
Norma Lanting
Business Analyst
